Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Double Cord Blood Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 0 results

Not applicableNo Longer AvailableNCT00423826
What this trial is testing

Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)WithdrawnNCT01652014
What this trial is testing

Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+51 more
University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Ended earlyNCT01745913
What this trial is testing

Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic SyndromeAcute Lymphocytic Leukemia+2 more
Weill Medical College of Cornell University 2
Testing effectiveness (Phase 2)Ended earlyNCT01464359
What this trial is testing

T-Cell Depleted Double UCB for Refractory AML

Who this might be right for
Acute Myelogenous LeukemiaRefractory Acute Myelogenous Leukemia
Masonic Cancer Center, University of Minnesota 3
Testing effectiveness (Phase 2)UnknownNCT00328237
What this trial is testing

Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+2 more
Colorado Blood Cancer Institute 20
Testing effectiveness (Phase 2)WithdrawnNCT01554254
What this trial is testing

Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation

Who this might be right for
Cord Blood TransplantHematologic MalignancyInherited Metabolic Disease
Tarix Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00763490
What this trial is testing

Trial Of Double Umbilical Cord Blood Transplantation

Who this might be right for
Hematological Malignancies
University of Michigan Rogel Cancer Center 20
Early research (Phase 1)Study completedNCT00890500
What this trial is testing

Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies.

Who this might be right for
Hematologic MalignanciesAllogeneic Stem Cell Transplantation
Fate Therapeutics 12
Testing effectiveness (Phase 2)Ended earlyNCT01627314
What this trial is testing

The PUMA Trial is a Trial of a Single ProHema Modulated-Cord Blood (CB) Unit as Part of a Double CB Transplant in Patients With Hematologic Malignancies.

Who this might be right for
Hematologic Malignancies
Fate Therapeutics 62
Testing effectiveness (Phase 2)Temporarily pausedNCT06680661
What this trial is testing

ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphatic LeukemiaChronic Myelogenous Leukemia+5 more
Leland Metheny 20
Large-scale testing (Phase 3)Study completedNCT01597778
What this trial is testing

Double Cord Versus Haploidentical (BMT CTN 1101)

Who this might be right for
Acute Lymphocytic LeukemiaAcute Myelogenous LeukemiaBurkitt's Lymphoma+4 more
Medical College of Wisconsin 368
Testing effectiveness (Phase 2)Study completedNCT01221857
What this trial is testing

Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)+2 more
Gamida Cell ltd 12
Not applicableLooking for participantsNCT06712108
What this trial is testing

Double Unit Cord Blood Transplant in Hematologic Malignancies.

Who this might be right for
Adult Double Unit Cord Blood Transplant
Seoul National University Hospital 40
Testing effectiveness (Phase 2)WithdrawnNCT01163201
What this trial is testing

T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies

Who this might be right for
Hematologic MalignancyAcute Myeloid LeukemiaAcute Lymphocytic Leukemia+14 more
Masonic Cancer Center, University of Minnesota
Testing effectiveness (Phase 2)Study completedNCT01690520
What this trial is testing

Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in Remission+2 more
Nohla Therapeutics, Inc. 163